This is a preview of subscription content, log in via an institution to check access.
Notes
HPRA = Health Products Regulatory Authority
including Roche, Novartis, Teva, Accord Healthcare, Clonmel Healthcare and Rowex.
Also see Reactions 1576 p4; 803151051
Reference
Starnawski M, et al. Mycophenolate mofetil (MMF)/mycophenolic acid (MPA): amended recommendations for contraception. Internet Document : 22 Jan 2018. Available from: URL: http://www.hpra.ie/docs/default-source/Safety-Notices/important-safety-information
Rights and permissions
About this article
Cite this article
Contraception recommended for use with mycophenolates. Reactions Weekly 1688, 1 (2018). https://doi.org/10.1007/s40278-018-41636-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-41636-y